PlainRecalls
FDA Drug Low Class III Terminated

Levofloxacin Tablets, USP 500 mg; 50-count bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540; Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India. NDC 33342-022-08

Reported: January 25, 2023 Initiated: January 5, 2023 #D-0162-2023

Product Description

Levofloxacin Tablets, USP 500 mg; 50-count bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540; Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India. NDC 33342-022-08

Reason for Recall

Mismatching of the embossing on the tablets (T7) with the embossing mentioned in the package insert (ML63) in the distributed bottles.

Details

Recalling Firm
MACLEODS PHARMA USA, INC
Units Affected
10052 bottles
Distribution
Nationwide within United States and Puerto Rico.
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Levofloxacin Tablets, USP 500 mg; 50-count bottles, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540; Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, India. NDC 33342-022-08. Recalled by MACLEODS PHARMA USA, INC. Units affected: 10052 bottles.
Why was this product recalled?
Mismatching of the embossing on the tablets (T7) with the embossing mentioned in the package insert (ML63) in the distributed bottles.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 25, 2023. Severity: Low. Recall number: D-0162-2023.